{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T22:58:44Z","timestamp":1770505124396,"version":"3.49.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1016\/j.biopsych.2005.03.029","type":"journal-article","created":{"date-parts":[[2005,5,6]],"date-time":"2005-05-06T22:48:44Z","timestamp":1115419724000},"page":"132-142","source":"Crossref","is-referenced-by-count":170,"title":["Cerebral Blood Flow Changes After Treatment of Social Phobia with the Neurokinin-1 Antagonist GR205171, Citalopram, or Placebo"],"prefix":"10.1016","volume":"58","author":[{"given":"Tomas","family":"Furmark","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lieuwe","family":"Appel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c5sa","family":"Michelg\u00e5rd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kurt","family":"Wahlstedt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fredrik","family":"\u00c5hs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Zancan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Jacobsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Flyckt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magnus","family":"Grohp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mats","family":"Bergstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilio Merlo","family":"Pich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars-G\u00f6ran","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Bani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bengt","family":"L\u00e5ngstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mats","family":"Fredrikson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2005.03.029_bib1","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nrn1056","article-title":"Cognitive neuroscience of human social behaviour","volume":"4","author":"Adolphs","year":"2003","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.biopsych.2005.03.029_bib2","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/0031-9384(96)00156-4","article-title":"Effects of microinjections of the neuropeptide substance P in the dorsal periaqueductal gray on the behaviour of rats in the plus-maze test","volume":"60","author":"Aguiar","year":"1996","journal-title":"Physiol Behav"},{"key":"10.1016\/j.biopsych.2005.03.029_bib3","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1126\/science.275.5308.1940","article-title":"Attentional activation of the cerebellum independent of motor involvement","volume":"275","author":"Allen","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2005.03.029_bib4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0006-3223(01)01307-5","article-title":"The primate amygdala and the neurobiology of social behavior","volume":"51","author":"Amaral","year":"2002","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2005.03.029_bib5","series-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"1994"},{"key":"10.1016\/j.biopsych.2005.03.029_bib6","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1517\/13543784.9.10.2215","article-title":"Drugs in development for social anxiety disorder","volume":"9","author":"Ameringen","year":"2000","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.biopsych.2005.03.029_bib7","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1097\/00004647-199609000-00005","article-title":"Sample size and statistical power in [15O]H2O studies of human cognition","volume":"16","author":"Andreasen","year":"1996","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.biopsych.2005.03.029_bib8","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0005-7967(01)00060-2","article-title":"The Liebowitz social anxiety scale as a self-report instrument","volume":"40","author":"Baker","year":"2002","journal-title":"Behav Res Ther"},{"key":"10.1016\/j.biopsych.2005.03.029_bib9","series-title":"Social Anxiety Disorder.","first-page":"267","article-title":"Pharmacotherapy of social anxiety disorder","author":"Bandelow","year":"2004"},{"key":"10.1016\/j.biopsych.2005.03.029_bib10","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/0013164487471024","article-title":"EXACON-a Fortran 77 program for the exact analysis of single cells in a contingency table","volume":"47","author":"Bergman","year":"1987","journal-title":"Educ Psychol Meas"},{"key":"10.1016\/j.biopsych.2005.03.029_bib11","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1097\/00001756-199804200-00048","article-title":"fMRI reveals amygdala activation to human faces in social phobics","volume":"9","author":"Birbaumer","year":"1998","journal-title":"Neuroreport"},{"key":"10.1016\/j.biopsych.2005.03.029_bib12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1192\/bjp.179.1.23","article-title":"Randomised controlled general practice trial of sertraline, exposure therapy and combined treatment in generalised social phobia","volume":"179","author":"Blomhoff","year":"2001","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.biopsych.2005.03.029_bib13","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1600-0447.1994.tb01604.x","article-title":"Axis V-Global assessment of functioning","volume":"90","author":"Bodlund","year":"1994","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.biopsych.2005.03.029_bib14","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s002130050915","article-title":"Clinical doses of fluoxetine and cerebral blood flow in healthy volunteers","volume":"143","author":"Bonne","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.biopsych.2005.03.029_bib15","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0143-4179(94)90079-5","article-title":"Effects of sequential removal of rats from a group cage, and of individual housing of rats, on substance P, cholecystokinin and somatostatin levels in the periaqueductal grey and limbic regions","volume":"26","author":"Brodin","year":"1994","journal-title":"Neuropeptides"},{"key":"10.1016\/j.biopsych.2005.03.029_bib16","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0005-7967(01)00086-9","article-title":"Patients with generalized social phobia direct their attention away from faces","volume":"40","author":"Chen","year":"2002","journal-title":"Behav Res Ther"},{"key":"10.1016\/j.biopsych.2005.03.029_bib17","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1037\/0033-2909.126.6.890","article-title":"Emotion, plasticity, context, and regulation","volume":"126","author":"Davidson","year":"2000","journal-title":"Psychol Bull"},{"key":"10.1016\/j.biopsych.2005.03.029_bib18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/sj.mp.4000812","article-title":"The amygdala","volume":"6","author":"Davis","year":"2001","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2005.03.029_bib19","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0924-977X(02)00102-5","article-title":"Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism","volume":"12","author":"Drevets","year":"2002","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2005.03.029_bib20","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0091-3057(97)90002-2","article-title":"Anxiolytic action of a neurokinin1 receptor antagonist in the social interaction test","volume":"58","author":"File","year":"1997","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.biopsych.2005.03.029_bib21","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s002130000513","article-title":"NKP608, an NK1 receptor antagonist, has an anxiolytic action in the social interaction test in rats","volume":"152","author":"File","year":"2000","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.biopsych.2005.03.029_bib22","series-title":"SCID-I","author":"First","year":"1998"},{"key":"10.1016\/j.biopsych.2005.03.029_bib23","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/hbm.460020402","article-title":"Statistical parametric maps in functional imaging","volume":"2","author":"Friston","year":"1995","journal-title":"Hum Brain Mapp"},{"key":"10.1016\/j.biopsych.2005.03.029_bib24","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1034\/j.1600-0447.2002.1r103.x","article-title":"Social phobia","volume":"105","author":"Furmark","year":"2002","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.biopsych.2005.03.029_bib25","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s001270050163","article-title":"Social phobia in the general population","volume":"34","author":"Furmark","year":"1999","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"10.1016\/j.biopsych.2005.03.029_bib26","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.neulet.2004.02.070","article-title":"Serotonin transporter polymorphism related to amygdala excitability and symptom severity in patients with social phobia","volume":"362","author":"Furmark","year":"2004","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.biopsych.2005.03.029_bib27","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/archpsyc.59.5.425","article-title":"Common changes in cerebral blood flow in patients with social phobia treated with citalopram or cognitive-behavioral therapy","volume":"59","author":"Furmark","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2005.03.029_bib28","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0167-0115(96)00071-7","article-title":"GR205171","volume":"65","author":"Gardner","year":"1996","journal-title":"Regul Pept"},{"issue":"suppl 4","key":"10.1016\/j.biopsych.2005.03.029_bib29","first-page":"33","article-title":"SSRIs and SMRIs","volume":"60","author":"Gorman","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.biopsych.2005.03.029_bib30","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1176\/appi.ajp.157.4.493","article-title":"Neuroanatomical hypothesis of panic disorder, revised","volume":"157","author":"Gorman","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2005.03.029_bib31","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00213-002-1112-4","article-title":"On serotonin and experimental anxiety","volume":"163","author":"Graeff","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.biopsych.2005.03.029_bib32","first-page":"61","article-title":"The neuropsychology of anxiety","volume":"43","author":"Gray","year":"1996","journal-title":"Nebr Symp Motiv"},{"key":"10.1016\/j.biopsych.2005.03.029_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0163-7258(98)00041-2","article-title":"Is there a future for neuropeptide receptor ligands in the treatment of anxiety disorders?","volume":"82","author":"Griebel","year":"1999","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.biopsych.2005.03.029_bib34","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1176\/jnp.9.2.198","article-title":"The neuroanatomy of 5-HT dysregulation and panic disorder","volume":"9","author":"Grove","year":"1997","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.biopsych.2005.03.029_bib35","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1126\/science.1071829","article-title":"Serotonin transporter genetic variation and the response of the human amygdala","volume":"297","author":"Hariri","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2005.03.029_bib36","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1054\/npep.2000.0824","article-title":"Substance P and its role in neural mechanisms governing learning, anxiety and functional recovery","volume":"34","author":"Hasenohrl","year":"2000","journal-title":"Neuropeptides"},{"key":"10.1016\/j.biopsych.2005.03.029_bib37","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00213-002-1218-8","article-title":"Occupancy of brain serotonin transporters during treatment with paroxetine in patients with social phobia","volume":"164","author":"Kent","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.biopsych.2005.03.029_bib38","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S0006-3223(02)01672-4","article-title":"Molecular targets in the treatment of anxiety","volume":"52","author":"Kent","year":"2002","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2005.03.029_bib39","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1126\/science.281.5383.1640","article-title":"Distinct mechanism for antidepressant activity by blockade of central substance P receptors","volume":"281","author":"Kramer","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2005.03.029_bib40","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/sj.npp.1300260","article-title":"Demonstration of the efficacy and safety of a novel substance P (NK1) receptor antagonist in major depression","volume":"29","author":"Kramer","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2005.03.029_bib41","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0166-4328(94)90053-1","article-title":"Substance P is involved in the sensitization of the acoustic startle response by footshocks in rats","volume":"63","author":"Krase","year":"1994","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.biopsych.2005.03.029_bib42","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8","article-title":"Automated Talairach atlas labels for functional brain mapping","volume":"10","author":"Lancaster","year":"2000","journal-title":"Hum Brain Mapp"},{"key":"10.1016\/j.biopsych.2005.03.029_bib43","series-title":"The Emotional Brain","author":"LeDoux","year":"1996"},{"key":"10.1016\/j.biopsych.2005.03.029_bib44","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1146\/annurev.neuro.23.1.155","article-title":"Emotion circuits in the brain","volume":"23","author":"LeDoux","year":"2000","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.biopsych.2005.03.029_bib45","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/BF00788510","article-title":"Assessing impairment in patients with panic disorder","volume":"27","author":"Leon","year":"1992","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"10.1016\/j.biopsych.2005.03.029_bib46","first-page":"2701","article-title":"Neural correlates of speech anticipatory anxiety in generalized social phobia","volume":"15","author":"Lorberbaum","year":"2004","journal-title":"Neuroreport"},{"key":"10.1016\/j.biopsych.2005.03.029_bib47","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S0166-2236(98)01374-5","article-title":"The retrosplenial cortex and emotion","volume":"22","author":"Maddock","year":"1999","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.biopsych.2005.03.029_bib48","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0005-7967(97)10031-6","article-title":"Development and validation of measures of social phobia scrutiny fear and social interaction anxiety","volume":"36","author":"Mattick","year":"1998","journal-title":"Behav Res Ther"},{"key":"10.1016\/j.biopsych.2005.03.029_bib49","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S0006-3223(00)01036-2","article-title":"Regional metabolic effects of fluoxetine in major depression","volume":"48","author":"Mayberg","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2005.03.029_bib50","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1126\/science.1703324","article-title":"Activity and distribution of binding sites in brain of a nonpeptide substance P (NK1) receptor antagonist","volume":"251","author":"McLean","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2005.03.029_bib51","series-title":"Insight vs. Desensitization in Psychotherapy","author":"Paul","year":"1966"},{"key":"10.1016\/j.biopsych.2005.03.029_bib52","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0278-5846(01)00331-1","article-title":"Participation of GABAA receptors in the modulation of experimental anxiety by tachykinin agonists and antagonists in mice","volume":"26","author":"Ribeiro","year":"2002","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2005.03.029_bib53","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0028-3908(03)00157-6","article-title":"Comparison of the functional blockade of rat substance P (NK1) receptors by GR205171, RP67580, SR140333 and NKP-608","volume":"45","author":"Rupniak","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopsych.2005.03.029_bib54","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0165-6147(99)01396-6","article-title":"Discovery of the antidepressant and anti-emetic efficacy of substance P receptor (NK1) antagonists","volume":"20","author":"Rupniak","year":"1999","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.biopsych.2005.03.029_bib55","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0163-7258(00)00082-6","article-title":"The psychobiology of anxiolytic drugs. Part 1: Basic neurobiology","volume":"88","author":"Sandford","year":"2000","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.biopsych.2005.03.029_bib56","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1073\/pnas.98.4.1912","article-title":"Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function","volume":"98","author":"Santarelli","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2005.03.029_bib57","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0006-3223(98)00269-8","article-title":"Subcortical correlates of differential classical conditioning of aversive emotional reactions in social phobia","volume":"45","author":"Schneider","year":"1999","journal-title":"Biol Psychiatry"},{"issue":"suppl 20","key":"10.1016\/j.biopsych.2005.03.029_bib58","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.)","volume":"59","author":"Sheehan","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.biopsych.2005.03.029_bib59","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0006-3223(01)01263-X","article-title":"Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment","volume":"50","author":"Sheline","year":"2001","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2005.03.029_bib60","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0006-8993(96)00812-8","article-title":"Reduction of substance P after chronic antidepressants treatment in the striatum, substantia nigra and amygdala of the rat","volume":"739","author":"Shirayama","year":"1996","journal-title":"Brain Res"},{"key":"10.1016\/j.biopsych.2005.03.029_bib61","series-title":"Manual for the State-Trait Anxiety Inventory","author":"Spielberger","year":"1970"},{"issue":"suppl 2","key":"10.1016\/j.biopsych.2005.03.029_bib62","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/00004850-200008002-00002","article-title":"Serotonin and anxiety","volume":"15","author":"Stein","year":"2000","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.biopsych.2005.03.029_bib63","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1001\/archpsyc.59.11.1027","article-title":"Increased amygdala activation to angry and contemptuous faces in generalized social phobia","volume":"59","author":"Stein","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2005.03.029_bib64","series-title":"Co-Planar Stereotaxic Atlas of the Human Brain","author":"Talairach","year":"1988"},{"key":"10.1016\/j.biopsych.2005.03.029_bib65","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0014-2999(96)00390-1","article-title":"Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice","volume":"311","author":"Teixeira","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.biopsych.2005.03.029_bib66","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1176\/appi.ajp.158.8.1220","article-title":"Cerebral blood flow in subjects with social phobia during stressful speaking tasks","volume":"158","author":"Tillfors","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2005.03.029_bib67","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0006-3223(02)01396-3","article-title":"Cerebral blood flow during anticipation of public speaking in social phobia","volume":"52","author":"Tillfors","year":"2002","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2005.03.029_bib68","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2165\/00023210-199911040-00006","article-title":"Selective serotonin reuptake inhibitors in the treatment of social phobia. The emerging gold standard","volume":"11","author":"Van Ameringen","year":"1999","journal-title":"CNS Drugs"},{"key":"10.1016\/j.biopsych.2005.03.029_bib69","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.pscychresns.2004.07.005","article-title":"A PET provocation study of generalized social phobia","volume":"132","author":"Van Ameringen","year":"2004","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.biopsych.2005.03.029_bib70","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0278-5846(99)00109-8","article-title":"Functional brain imaging and pharmacotherapy in social phobia","volume":"24","author":"van der Linden","year":"2000","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2005.03.029_bib71","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0893-133X(02)00313-5","article-title":"The gerbil elevated plus-maze II","volume":"27","author":"Varty","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2005.03.029_bib72","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0304-3940(02)00519-0","article-title":"Brain circuits involved in emotional learning in antisocial behavior and social phobia in humans","volume":"328","author":"Veit","year":"2002","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.biopsych.2005.03.029_bib73","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0924-9338(00)00211-X","article-title":"Disability and quality of life in pure and comorbid social phobia. Findings from a controlled study","volume":"15","author":"Wittchen","year":"2000","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.biopsych.2005.03.029_bib74","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1176\/appi.ps.52.5.637","article-title":"An eight-year longitudinal comparison of clinical course and characteristics of social phobia among men and women","volume":"52","author":"Yonkers","year":"2001","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.biopsych.2005.03.029_bib75","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1017\/S0033291703007414","article-title":"Evaluation of the clinical global impression scale among individuals with social anxiety disorder","volume":"33","author":"Zaider","year":"2003","journal-title":"Psychol Med"},{"key":"10.1016\/j.biopsych.2005.03.029_bib76","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0969-8051(01)00275-X","article-title":"Estimate the time varying brain receptor occupancy in PET imaging experiments using non-linear fixed and mixed effect modeling approach","volume":"29","author":"Zamuner","year":"2002","journal-title":"Nucl Med Biol"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322305003720?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322305003720?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,26]],"date-time":"2019-01-26T17:50:24Z","timestamp":1548525024000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322305003720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":76,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S0006322305003720"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2005.03.029","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}